683 Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,400,000
| Closed | -$7.99M | – | 129 |
|
|
2025
Q1 | $7.99M | Buy |
2,400,000
+983,986
| +69% | +$3.28M | 0.55% | 42 |
|
|
2024
Q4 | $10.5M | Buy |
1,416,014
+16,014
| +1% | +$119K | 0.65% | 31 |
|
|
2024
Q3 | $13.1M | Sell |
1,400,000
-100,000
| -7% | -$939K | 1% | 25 |
|
|
2024
Q2 | $12M | Buy |
1,500,000
+275,000
| +22% | +$2.21M | 0.91% | 30 |
|
|
2024
Q1 | $18.2M | Sell |
1,225,000
-525,000
| -30% | -$7.78M | 1.33% | 18 |
|
|
2023
Q4 | $14.2M | Sell |
1,750,000
-300,000
| -15% | -$2.44M | 1.17% | 27 |
|
|
2023
Q3 | $9.33M | Buy |
2,050,000
+650,000
| +46% | +$2.96M | 0.73% | 38 |
|
|
2023
Q2 | $9.86M | Buy |
1,400,000
+75,000
| +6% | +$528K | 0.71% | 32 |
|
|
2023
Q1 | $8.1M | Buy |
1,325,000
+325,000
| +33% | +$1.99M | 0.6% | 41 |
|
|
2022
Q4 | $6.39M | Sell |
1,000,000
-705,000
| -41% | -$4.5M | 0.54% | 47 |
|
|
2022
Q3 | $16.3M | Sell |
1,705,000
-295,000
| -15% | -$2.83M | 1.26% | 27 |
|
|
2022
Q2 | $22.1M | Buy |
2,000,000
+500,000
| +33% | +$5.52M | 1.56% | 17 |
|
|
2022
Q1 | $25M | Buy |
1,500,000
+780,000
| +108% | +$13M | 1.34% | 15 |
|
|
2021
Q4 | $13.7M | Sell |
720,000
-229,829
| -24% | -$4.39M | 0.51% | 39 |
|
|
2021
Q3 | $23.4M | Sell |
949,829
-75,000
| -7% | -$1.85M | 0.91% | 22 |
|
|
2021
Q2 | $26.7M | Buy |
+1,024,829
| New | +$26.7M | 0.92% | 21 |
|
|
2021
Q1 | – | Sell |
-100,000
| Closed | -$4.64M | – | 193 |
|
|
2020
Q4 | $4.64M | Hold |
100,000
| – | – | 0.22% | 59 |
|
|
2020
Q3 | $3.29M | Hold |
100,000
| – | – | 0.24% | 58 |
|
|
2020
Q2 | $2.75M | Hold |
100,000
| – | – | 0.22% | 57 |
|
|
2020
Q1 | $2.99M | Buy |
+100,000
| New | +$2.99M | 0.35% | 47 |
|
|
2018
Q3 | – | Sell |
-350,000
| Closed | -$4.48M | – | 148 |
|
|
2018
Q2 | $4.48M | Hold |
350,000
| – | – | 0.3% | 44 |
|
|
2018
Q1 | $5.92M | Buy |
350,000
+50,000
| +17% | +$845K | 0.52% | 35 |
|
|
2017
Q4 | $2.4M | Hold |
300,000
| – | – | 0.2% | 59 |
|
|
2017
Q3 | $2.33M | Buy |
+300,000
| New | +$2.33M | 0.24% | 53 |
|